4//SEC Filing
CARVER JENNIFER 4
Accession 0000920465-19-000001
CIK 0000920465other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 7:51 PM ET
Size
7.0 KB
Accession
0000920465-19-000001
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Common Stock
2018-12-31$8.02/sh+148$1,186→ 7,116 total - Award
Stock Option (Right to Buy)
2018-12-31+148→ 148 totalExercise: $9.43Exp: 2028-12-31→ Common Stock (148 underlying)
Footnotes (2)
- [F1]These shares were acquired on 12/31/2018 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.
Documents
Issuer
LA JOLLA PHARMACEUTICAL CO
CIK 0000920465
Entity typeother
Related Parties
1- filerCIK 0001663163
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 7:51 PM ET
- Size
- 7.0 KB